The Tumor Suppressor CYLD Controls the Function of Murine Regulatory T Cells
The Tumor Suppressor CYLD Controls the Function of Murine Regulatory T Cells
复制标题
DOI:
10.4049/jimmunol.1201993
复制
发表时间:
2012-11-15
影响因子:
4.4
通讯作者:
Waisman, Ari
中科院分区:
文献类型:
--
作者:
Reissig, Sonja;Hoevelmeyer, Nadine;Waisman, Ari
CYLD was originally identified as a tumor suppressor gene mutated in familial cylindromatosis, an autosomal dominant predisposition to multiple benign neoplasms of the skin known as cylindromas. The CYLD protein is a deubiquitinating enzyme that acts as a negative regulator of NF-kappa B and JNK signaling through its interaction with NEMO and TNFR-associated factor 2. We have previously described a novel mouse strain that expresses solely and excessively a naturally occurring splice variant of CYLD (CYLDex7/8). In this study, we demonstrate that CYLD plays a critical role in Treg development and function. T cells of CYLDex7/8 mice had a hyperactive phenotype manifested by increased production of inflammatory cytokines and constitutive activation of the NF-kB pathway. Furthermore, the amount of Foxp(3+) regulatory T cells in these mice was markedly enhanced in thymus and peripheral organs. Importantly, these regulatory T cells displayed decreased expression levels of CD25 and CTLA-4 associated with impaired suppressive capacity. Hence, our data emphasize an essential role of CYLD in maintaining T cell homeostasis as well as normal T regulatory cell function, thereby controlling abnormal T cell responses. The Journal of Immunology, 2012, 189: 4770-4776.